TCRT logo

Alaunos Therapeutics (TCRT)

Profile

Full Name

Alaunos Therapeutics, Inc.

Ticker Symbol

TCRT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 24, 2005

Indexes

Not included

Website

http://www.alaunos.com

Employees

1

Key Details

Price

$2.92(+2.10%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.00K(+100.00% YoY)

Annual EPS

-$2.92(+86.71% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.92
TCRT price is $2.92

30-Day Relative Volume

0.14
TCRT 30-day relative volume is 0.14

Price Performance

Price Most recent change

+2.1%
TCRT price was up +2.1% on Apr 11, 2025

Price YTD change

+52.88%
TCRT price is up +52.88% since January 1st

Price 1-year change

-82.51%
TCRT price is down -82.51% year-on-year

Price 3-year change

-96.11%
TCRT price is down -96.11% over the past 3 years

Price Range

Price All-time high

$2400.00
TCRT price is currently -99.88% below its historical high of $2400.00

Price 3-year low

$0.60
TCRT price is currently +386.67% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.68M
TCRT market capitalization is $4.68 million

Market cap 3-year change

-95.67%
TCRT market capitalization is down -95.67% over the past 3 years

Market cap All-time high

$1.91B
TCRT market capitalization is currently -99.75% below its historical high of $1.91 billion

Market cap sector rank

12.57%
TCRT market capitalization is higher than 12.57% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.01%
TCRT shares outstanding is up +0.01% year-on-year

Shares Outstanding 3-Year Change

+11.22%
TCRT shares outstanding is up +11.22% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.11
TCRT beta is 0.11

200-day SMA

$2.59
TCRT price is currently +12.92% above its 200-day simple moving average

50-day SMA

$1.80
TCRT price is currently +62.42% above its 50-day simple moving average

RSI

60.63
TCRT 14-day relative strength index is 60.63

Volume

0.14
TCRT 30-day relative volume is 0.14

ATR

$0.71
TCRT average true range is $0.71

10-day Historical Volatility

409.38%
TCRT 10-day historical volatility is 409.38%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$10.00K
TCRT annual revenue is $10.00 thousand

Revenue Analysts estimate

$556.93M
TCRT annual revenue is currently -100.00% lower than the consensus analysts' forecast

Revenue 1-year change

+100%
TCRT annual revenue is up +100% year-on-year

Revenue Sector rank

2.13%
TCRT annual revenue is higher than 2.13% of companies in Healthcare sector

EPS

EPS

-$2.92
TCRT annual earnings per share is -$2.92

EPS Analysts estimate

-
TCRT annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+86.71%
TCRT annual earnings per share is up +86.71% year-on-year

EPS Sector rank

30.39%
TCRT annual earnings per share is higher than 30.39% of companies in Healthcare sector

Profit

Gross profit

-
TCRT annual gross profit value is unknown

Gross margin

-
TCRT annual gross profit margin value is unknown

Operating profit

-$4.81M
TCRT annual operating income is -$4.81 million

Operating margin

-48.12K%
TCRT annual operating profit margin is -48.12 thousand%

Net income

-$4.68M
TCRT annual net profit is -$4.68 million

Net margin

-46.79K%
TCRT annual net profit margin is -46.79 thousand%

Expenses

Total expenses

$4.82M
TCRT annual total expenses is $4.82 million

Operating expenses

$4.82M
TCRT annual total operating expenses is $4.82 million

Cost of goods sold

-
TCRT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.46M
TCRT annual SGA is $4.46 million

Depreciation and amortization

$2000.00
TCRT annual depreciation & amortization is $2000.00

Interest expense

$0.00
TCRT annual interest expense is $0.00

Income tax

-
TCRT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$4.68M
TCRT annual earnings before interest & taxes is -$4.68 million

EBITDA

-$4.68M
TCRT annual EBITDA is -$4.68 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.75M
TCRT annual total assets is $2.75 million

Non current assets

$0.00
TCRT annual long term assets is $0.00

Current assets

$2.75M
TCRT annual total current assets is $2.75 million

Cash and cash equivalents

$1.09M
TCRT annual cash & cash equivalents is $1.09 million

Accounts receivable

$5000.00
TCRT annual accounts receivable is $5000.00

Inventory

-
TCRT annual inventory value is unknown

Liabilities

Total liabilities

$692.00K
TCRT annual total liabilities is $692.00 thousand

Long term liabilities

$0.00
TCRT annual total long term liabilities is $0.00

Current liabilities

$692.00K
TCRT annual total current liabilities is $692.00 thousand

Accounts payable

$516.00K
TCRT annual accounts payable is $516.00 thousand

Debt

Total debt

$0.00
TCRT annual total debt is $0.00

Total debt 1-year change

0%
TCRT {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
TCRT annual long term debt value is unknown

Short term debt

-
TCRT annual short term debt value is unknown

Equity & Capital

Shareholders equity

$2.06M
TCRT annual stockholders equity is $2.06 million

Book value

$2.06M
TCRT annual book value is $2.06 million

Retained earnings

-$920.45M
TCRT annual retained earnings is -$920.45 million

Working capital

$2.06M
TCRT annual working capital is $2.06 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$4.97M
TCRT annual cash flow from operations is -$4.97 million

Cash from operations 1-year change

+83.51%
TCRT annual cash flow from operations is up +83.51% year-on-year

Cash from investing

$0.00
TCRT annual cash flow from investing activities is $0.00

Cash from investing 1-year change

-100%
TCRT annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$0.00
TCRT annual cash flow from financing activities is $0.00

Cash from financing 1-year change

+100%
TCRT annual cash flow from financing activities is up +100% year-on-year

CAPEX

CAPEX

-
TCRT annual capital expenditures value is unknown

CAPEX 1-year change

-
TCRT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$4.97M
TCRT annual free cash flow is -$4.97 million

Free cash flow 1-year change

+83.62%
TCRT annual free cash flow is up +83.62% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
TCRT annual gross profit margin value is unknown

Operating margin

-48.12K%
TCRT annual operating profit margin is -48.12 thousand%

Net margin

-46.79K%
TCRT annual net profit margin is -46.79 thousand%

ROA & ROE

ROA

-84.93%
TCRT annual return on assets is -84.93%

ROE

-111.80%
TCRT annual return on equity is -111.80%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TCRT price to earnings ratio value is unknown

PE ratio Sector rank

-
TCRT price to earnings ratio is unknown

PB Ratio

PB ratio

2.27
TCRT price to book ratio is 2.27

PB ratio Sector rank

66.61%
TCRT price to book ratio is higher than 66.61% of companies in Healthcare sector

PS Ratio

PS ratio

519.53
TCRT price to sales ratio is 519.53

PS ratio Sector rank

97.82%
TCRT price to sales ratio is higher than 97.82% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.58M
TCRT enterprise value is $3.58 million

Enterprise value Sector rank

18.47%
TCRT enterprise value is higher than 18.47% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.77
TCRT EV/EBITDA is -0.77

EV/EBITDA Sector rank

46.7%
TCRT EV/EBITDA is higher than 46.7% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.98
TCRT annual current ratio is 3.98

Quick ratio

-
TCRT annual quick ratio value is unknown

Leverage

Debt to equity

0.00
TCRT annual debt to equity ratio is 0.00

Interest coverage ratio

-
TCRT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
TCRT piotroski f-score value is unknown

Altman Z-Score

-468.39
TCRT altman z-score is -468.39

Analyst ratings

Recent major analysts updates

Aug 16, 23 HC Wainwright & Co.
Neutral
Aug 15, 23 Laidlaw & Co.
Hold
May 15, 23 HC Wainwright & Co.
Buy
May 4, 22 Wells Fargo
Overweight
Nov 9, 21 Raymond James
Market Perform
Aug 10, 21 Raymond James
Market Perform
May 7, 21 Raymond James
Outperform
Mar 12, 21 Jefferies
Hold
Mar 1, 21 HC Wainwright & Co.
Neutral
Jun 19, 20 Jefferies
Buy

Institutional Ownership

Similar stocks

ADIL logo
Adial Pharmaceuticals (ADIL)
BCLI logo
Brainstorm Cell Therapeutics (BCLI)
SILO logo
Silo Pharma (SILO)
SINT logo
Sintx Technologies (SINT)
CPHI logo
China Pharma Holdings (CPHI)
NCNA logo
NuCana (NCNA)
VRAX logo
Virax Biolabs Group Limited (VRAX)
Klotho Neurosciences (KLTO)
ACON logo
Aclarion (ACON)
  • What is the ticker symbol for Alaunos Therapeutics?
  • Does Alaunos Therapeutics pay dividends?
  • What sector is Alaunos Therapeutics in?
  • What industry is Alaunos Therapeutics in?
  • What country is Alaunos Therapeutics based in?
  • When did Alaunos Therapeutics go public?
  • Is Alaunos Therapeutics in the S&P 500?
  • Is Alaunos Therapeutics in the NASDAQ 100?
  • Is Alaunos Therapeutics in the Dow Jones?
  • When was Alaunos Therapeutics's last earnings report?
  • When does Alaunos Therapeutics report earnings?
  • Should I buy Alaunos Therapeutics stock now?

What is the ticker symbol for Alaunos Therapeutics?

The ticker symbol for Alaunos Therapeutics is NASDAQ:TCRT

Does Alaunos Therapeutics pay dividends?

No, Alaunos Therapeutics does not pay dividends

What sector is Alaunos Therapeutics in?

Alaunos Therapeutics is in the Healthcare sector

What industry is Alaunos Therapeutics in?

Alaunos Therapeutics is in the Biotechnology industry

What country is Alaunos Therapeutics based in?

Alaunos Therapeutics is headquartered in United States

When did Alaunos Therapeutics go public?

Alaunos Therapeutics's initial public offering (IPO) was on August 24, 2005

Is Alaunos Therapeutics in the S&P 500?

No, Alaunos Therapeutics is not included in the S&P 500 index

Is Alaunos Therapeutics in the NASDAQ 100?

No, Alaunos Therapeutics is not included in the NASDAQ 100 index

Is Alaunos Therapeutics in the Dow Jones?

No, Alaunos Therapeutics is not included in the Dow Jones index

When was Alaunos Therapeutics's last earnings report?

Alaunos Therapeutics's most recent earnings report was on Nov 14, 2024

When does Alaunos Therapeutics report earnings?

The next expected earnings date for Alaunos Therapeutics is May 9, 2025

Should I buy Alaunos Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page